Reolysin in Combination With FOLFOX6 and Bevacizumab or FOLFOX6 and Bevacizumab Alone in Metastatic Colorectal Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01622543
Recruitment Status : Active, not recruiting
First Posted : June 19, 2012
Last Update Posted : February 1, 2018
Oncolytics Biotech
Information provided by (Responsible Party):
Canadian Cancer Trials Group